These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38437)

  • 1. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
    Schümichen C; Hohloch M; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.
    Schümichen C; Hohloch H; Schiller A; Pohle W; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):98-104. PubMed ID: 38438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
    J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexes of technetium with pyrophosphate, etidronate, and medronate.
    Russell CD; Cash AG
    J Nucl Med; 1979 Jun; 20(6):532-7. PubMed ID: 43885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
    Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
    J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dose distribution of bone-seeking radiopharmaceuticals in the rat (author's transl)].
    Schümichen C; Hermannsdörfer A; Wüst H; Hoffmann G
    Strahlentherapie; 1979 Nov; 155(11):796-801. PubMed ID: 117574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid.
    Tofe AJ; Francis MD
    J Nucl Med; 1976 Sep; 17(9):820-5. PubMed ID: 822138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. II. In vitro studies.
    Schümichen C; Mackenbrock B; Hoffmann G
    Nuklearmedizin; 1977 Aug; 16(4):157-62. PubMed ID: 198752
    [No Abstract]   [Full Text] [Related]  

  • 9. Formation and in-vivo-distribution of different 99mTc-Sn-pyrophosphate complexes.
    Schümichen C; Roth KH; Hoffmann G
    Nucl Med (Stuttg); 1975 Dec; 14(4):323-9. PubMed ID: 2905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S; Kalincák M; Machán V
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting uptake and retention of technetium-99m-diphosphonate and 99m-pertechnetate in osseous, connective and soft tissues.
    Francis MD; Slough CL; Tofe AJ
    Calcif Tissue Res; 1976 Jun; 20(3):303-11. PubMed ID: 182328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concentration of 99mTc-tin-phosphate complexes in soft tissues].
    Büll U; von Lieven H; Leisner B
    Nucl Med (Stuttg); 1975 Jun; 14(2):91-105. PubMed ID: 170592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
    Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
    J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of radiochemical purity and pharmacokinetic parameters of 99mTc-sulphur colloid and 99mTc-tin colloid.
    Jovanović V; Konstantinovska D; Milivojević K; Bzenić J
    Nuklearmedizin; 1981 Dec; 20(6):279-82. PubMed ID: 7329810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
    Atamaniuk NP; Mechev DS
    Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 99mTc-labelled polyphosphate, pyrophosphate and ethane hydroxy diphosphonate in patients with skeletal metastases and in normal subjects.
    Citrin DL; Bessent RG; Tuohy JB; Elms ST; McGinlay E; Greig WR; Blumgart LH
    Strahlentherapie Sonderb; 1975; 74():321-8. PubMed ID: 173049
    [No Abstract]   [Full Text] [Related]  

  • 17. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo behaviour of four different 99(m)Tc-HEDP complexes.
    Inoue O; Yamaguchi T; Ikeda I
    Nuklearmedizin; 1982 Dec; 21(6):227-31. PubMed ID: 6820139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-labeled stannous imidodiphosphate, a new radiodiagnostic agent for bone scanning: comparison with other 99mTc complexes.
    Subramanian G; McAfee JG; Blair RJ; Rosenstreich M; Coco M; Duxbury CE
    J Nucl Med; 1975 Dec; 16(12):1137-43. PubMed ID: 1194964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two different HEDP content kits: stability study against dilution both in vivo and in vitro.
    Inoue O; Ikeda I; Kurata K
    Nuklearmedizin; 1982 Jun; 21(3):121-5. PubMed ID: 6813826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.